Aug 6 (Reuters) - CM Life Sciences III Inc :
* CM LIFE SCIENCES III INC SAYS MELANIE NALLICHERI HAS BEEN APPOINTED CHIEF EXECUTIVE OFFICER OF EQRX
* CM LIFE SCIENCES III INC SAYS ALEXIS BORISY HAS BEEN APPOINTED EXECUTIVE CHAIRMAN OF EQRX'S BOARD OF DIRECTORS
* CM LIFE SCIENCES III INC - TRANSACTION IS EXPECTED TO PROVIDE UP TO $1.8 BILLION IN CASH PROCEEDS TO EQRX
* CM LIFE SCIENCES III INC - UPON CLOSING OF BUSINESS COMBINATION, CM LIFE SCIENCES III WILL BE RENAMED "EQRX, INC."
* CM LIFE SCIENCES III - UPON CLOSING, COMBINED CO'S COMMON STOCK, WARRANTS EXPECTED TO REMAIN LISTED ON NASDAQ GLOBAL MARKET UNDER TICKER SYMBOLS "EQRX" & "EQRXW," RESPECTIVELY
* CM LIFE SCIENCES III INC - DEAL FINANCING INCLUDES FULLY COMMITTED PRIVATE PLACEMENT OF COMMON STOCK OF $1.2 BILLION AT $10.00 PER SHARE
* CM LIFE SCIENCES III - PIPE FROM INVESTORS, LED BY SB NORTHSTAR LP AND INCLUDING FUNDS ADVISED BY CASDIN CAPITAL AND CORVEX MANAGEMENT
* CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE FIDELITY MANAGEMENT & RESEARCH, FRANKLIN TEMPLETON ANDREESSEN HOROWITZ (A16Z)
* CM LIFE SCIENCES III - PARTICIPANTS IN PIPE INCLUDE ANDREESSEN HOROWITZ (A16Z), MUBADALA INVESTMENT & ASSET MANAGEMENT UNIT, MUBADALA CAPITAL, VERILY, OTHERS
* CM LIFE SCIENCES III - AS PART OF DEAL, EQRX STOCKHOLDERS WILL RECEIVE COMMON STOCK OF CM LIFE SCIENCES III IN EXCHANGE FOR SHARES OF EQRX
* CM LIFE SCIENCES III - DEAL VALUES EQRX AT PRE-TRANSACTION ENTERPRISE VALUE OF $3.65 BILLION WITH ADDITIONAL $500 MILLION POTENTIAL PERFORMANCE BASED EARNOUT
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))